Novavax, Inc (NASDAQ:NVAX) price on Wednesday, November 13, fall -8.22% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $7.76. A look at the stock’s price movement, the close in the last trading session was $8.46, moving within
Novavax, Inc (NASDAQ:NVAX) price closed lower on Friday, November 08, and dropping -2.94% below its previous close. A look at the daily price movement shows that the last close reads $9.18, with intraday deals fluctuated between $8.845 and $9.25. The company’s 5Y monthly beta was
Novavax, Inc (NASDAQ:NVAX) concluded the trading at $8.96 on Wednesday, November 06 with with a fall of -5.08% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $9.44 and 5Y monthly beta
Novavax, Inc (NASDAQ:NVAX) traded at $9.35 at close of the session on Friday, November 01 and made a downward move of -2.71% on its previous day’s price. Looking at the stock we see that its previous close was $9.61 and the beta (5Y monthly) reads
Novavax, Inc. (NASDAQ:NVAX) shares, rose in value, with the stock price down by -2.28% to the previous day’s close as strong demand from buyers drove the stock to $9.84. Actively observing the price movement in the last trading, the stock closed the session at $10.07,
Shares of US biotech company Novavax at the August 5 aftermarket trading rose 5%, then plunged more than 17% to $204.76 each. The plunge was in response to the upcoming transfer of the application to the United States Food and Drug Administration (FDA) for approval
In the biotechnology industry, companies produce drugs that treat illness and diagnostic technologies. For these products to be approved by the FDA, the process is lengthy and expensive. Food and Drug Administration (FDA). In this case, investors may have to wait years to find out
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
